Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Irinotecan in Second Line Metastatic Gastric Cancer
NCT04770623Phase 2Completed
- Sponsor
- Menoufia University
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, irinotecan in gastric cancer (GC), sponsored by Menoufia University. Started Mar 2021; status: completed.
02
Drugs
docetaxelirinotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04770623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04770623.